Study Summary
This trial will test a tailored program for 40 young adults with cancer to see if it meets criteria and is easy/acceptable to use.
- Medication Adherence
- Cancer
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 11 Secondary · Reporting Duration: End of study enrollment period, approximately 12 months after enrollment initiation
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
1 Treatment Group
Tailored Program
1 of 1
Experimental Treatment
40 Total Participants · 1 Treatment Group
Primary Treatment: Tailored Program · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 15 - 24 · All Participants · 0 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are individuals who are below the age of 80 being admitted to this medical trial?
"Participants must be between 15 and 24 years old in order to qualify for this clinical trial." - Anonymous Online Contributor
What are the eligibility criteria for participation in this trial?
"This clinical trial is welcoming 40 individuals aged 15-24 who have been diagnosed with cancer and are currently taking oral chemotherapy or prophylactic medication. It is essential that applicants meet these criteria before applying for the study." - Anonymous Online Contributor
Are there any vacancies to join this scientific exploration?
"According to the clinicaltrials.gov database, this study is not presently accepting new participants. Initially posted on February 6th 2023 and last edited January 20th 2023, it appears that recruitment has ended for the time being. There are still 556 other trials actively seeking patients at present though." - Anonymous Online Contributor